Johnson & Johnson
JNJ
#19
Rank
C$797.85 B
Marketcap
C$331.07
Share price
0.49%
Change (1 day)
39.58%
Change (1 year)

Johnson & Johnson is a global American pharmaceutical and consumer goods company with headquarters in New Brunswick, New Jersey. The company is listed in the Dow Jones Industrial Average.

Earnings for Johnson & Johnson (JNJ)

Earnings in 2024: C$23.68 Billion

According to Johnson & Johnson's latest financial reports the company's current earnings are C$92.14 Billion. In 2024 the company made an earning of C$23.68 Billion, an increase over its 2023 earnings that were of C$21.50 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Johnson & Johnson from 1984 to 2024

Annual earnings

Year Earnings Change
2024C$23.68 B10.16%
2023C$21.50 B-25.84%
2022C$28.99 B-7%
2021C$31.18 B37.5%
2020C$22.67 B-5.37%
2019C$23.96 B-7.15%
2018C$25.80 B2.13%
2017C$25.26 B-9.36%
2016C$27.88 B3.95%
2015C$26.81 B-6.39%
2014C$28.65 B32.24%
2013C$21.66 B11.5%
2012C$19.43 B10.63%
2011C$17.56 B-25.69%
2010C$23.63 B7.38%
2009C$22.00 B-9.81%
2008C$24.40 B18.12%
2007C$20.66 B10.97%
2006C$18.61 B5.73%
2005C$17.60 B0.79%
2004C$17.47 B18.33%
2003C$14.76 B12.33%
2002C$13.14 B22.74%
2001C$10.70 B19.71%
2000C$8.94 B10.13%
1999C$8.12 B18.55%
1998C$6.85 B9.15%
1997C$6.27 B7.41%
1996C$5.84 B20.67%
1995C$4.84 B27.04%
1994C$3.81 B17.4%
1993C$3.24 B5.01%
1992C$3.09 B5.22%
1991C$2.93 B5.51%
1990C$2.78 B
1988C$1.90 B16.12%
1987C$1.64 B22.93%
1986C$1.33 B17.1%
1985C$1.14 B12.68%
1984C$1.01 B

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Novartis
NVS
C$22.20 B-49.52%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
C$16.09 B-63.42%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
C$11.05 B-74.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Medtronic
MDT
C$8.70 B-80.21%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Eli Lilly
LLY
C$30.56 B-30.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
C$12.35 B-71.91%๐Ÿ‡ซ๐Ÿ‡ท France
Gilead Sciences
GILD
C$13.42 B-69.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Stryker Corporation
SYK
C$4.53 B-89.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
C$31.35 B-28.73%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
C$12.66 B-71.22%๐Ÿ‡ฌ๐Ÿ‡ง UK